Overview

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms

Status:
Completed

Trial end date:
2011-11-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of long term escitalopram treatment in participants with Major Depressive Disorder (MDD) with associated anxiety symptoms.

Phase:

Phase 4

Details

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Treatments:

Citalopram
Dexetimide